The Zacks Analyst Blog Highlights: Texas Instruments, Gilead Sciences and Las Vegas Sands

For Immediate Release

Chicago, IL – July 26, 2016 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include Texas Instruments (TXN), Gilead Sciences ( GILD) and Las Vegas Sands (LVS).

Today, Zacks is promoting its ''Buy'' stock recommendations. Get #1Stock of the Day pick for free.

Here are highlights from Monday’s Analyst Blog:

Q2 Earnings After the Bell Monday: TXN, GILD & LVS

Following a market pullback upon oil prices falling to their lowest levels in three months, the next wave of Q2 earnings have begun to be released after the bell today. Texas Instruments (TXN) , Gilead Sciences (GILD) and Las Vegas Sands ( LVS) are among the smorgasbord of Q2 earnings reports today.

Texas Instruments posted a solid beat on both top and bottom lines this afternoon, with earnings of 76 cents per share eclipsing the 72 cents expected. Revenues of $3.27 billion beat the $3.20 billion from the Zacks consensus. Diversifies business streams -- especially in the automotive and commercial equipment markets -- helped offset some of TI's headwinds related to iPhone sales. This is the company's fourth straight earnings beat, and the stock, already trading at 15 year highs, is up another 5.75% upon the news.

Gilead Sciences beat earnings estimates by 6 cents per share, but came in light on revenues. EPS of $3.08 on quarterly sales of $7.78 billion, which missed the $7.85 billion in the Zacks consensus estimate. Full year revenue guidance was lowered below $30 billion on the low range. Sales in Gilead's Hep-C market reached $3.92 billion, missing the $4.1 billion analysts had been expecting. GILD shares fell 4.3% on the earnings news, but have since come back a bit. Over the past year, Gilead is down more than 21%. Read more on Gilead's Q2 earnings here.

Las Vegas Sands, however, missed estimates on both earnings and revenues: 52 cents per share was lower than the 56 cents expected, and $2.65 billion was far below the $2.75 billion in the Zacks consensus. CEO Sheldon Adelson called the current environment "challenging," though he did cite some signs of stabilization in gaming growth increases looking forward. But all LVS' Macau businesses were lower the the quarter, and Q2 represents the company's third straight earnings miss. The stock traded down nearly 1.8% following the earnings news.

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>

Today, Zacks is promoting its ''Buy'' stock recommendations. Get #1Stock of the Day pick for free.

About Zacks Equity Research

Zacks Equity Research provides the best of quantitative and qualitative analysis to help investors know what stocks to buy and which to sell for the long-term.

Continuous coverage is provided for a universe of 1,150 publicly traded stocks. Our analysts are organized by industry which gives them keen insights to developments that affect company profits and stock performance. Recommendations and target prices are six-month time horizons.

Zacks "Profit from the Pros" e-mail newsletter provides highlights of the latest analysis from Zacks Equity Research. Subscribe to this free newsletter today.

About Zacks

Zacks.com is a property of Zacks Investment Research, Inc., which was formed in 1978. The later formation of the Zacks Rank, a proprietary stock picking system; continues to outperform the market by nearly a 3 to 1 margin. The best way to unlock the profitable stock recommendations and market insights of Zacks Investment Research is through our free daily email newsletter; Profit from the Pros. In short, it's your steady flow of Profitable ideas GUARANTEED to be worth your time! Register for your free subscription to Profit from the Pros.

Follow us on Twitter: https://twitter.com/zacksresearch

Join us on Facebook: https://www.facebook.com/home.php#/pages/Zacks-Investment-Research/57553657748?ref=ts

Zacks Investment Research is under common control with affiliated entities (including a broker-dealer and an investment adviser), which may engage in transactions involving the foregoing securities for the clients of such affiliates.

Media Contact

Zacks Investment Research

800-767-3771 ext. 9339

support@zacks.com

https://www.zacks.com

Past performance is no guarantee of future results. Inherent in any investment is the potential for loss. This material is being provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. It should not be assumed that any investments in securities, companies, sectors or markets identified and described were or will be profitable. All information is current as of the date of herein and is subject to change without notice. Any views or opinions expressed may not reflect those of the firm as a whole. Zacks Investment Research does not engage in investment banking, market making or asset management activities of any securities. These returns are from hypothetical portfolios consisting of stocks with Zacks Rank = 1 that were rebalanced monthly with zero transaction costs. These are not the returns of actual portfolios of stocks. The S&P 500 is an unmanaged index. Visit https://www.zacks.com/performance for information about the performance numbers displayed in this press release.


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
TEXAS INSTRS (TXN): Free Stock Analysis Report
 
GILEAD SCIENCES (GILD): Free Stock Analysis Report
 
LAS VEGAS SANDS (LVS): Free Stock Analysis Report
 
To read this article on Zacks.com click here.

Advertisement